Rheumatoid Arthritis Prevention

Cross-source consensus on Rheumatoid Arthritis Prevention from 1 sources and 5 claims.

1 sources · 5 claims

Uses

The prevention concept involves identifying higher-risk people before persistent rheumatoid arthritis and intervening during a window of opportunity. — Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
In ARIAA, rheumatoid arthritis was diagnosed less often with abatacept than placebo among patients with arthralgia, ACPA positivity, and MRI subclinical inflammation. — Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
In APIPPRA, abatacept lengthened time to rheumatoid arthritis compared with placebo. — Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
Abatacept has shown preventive or delaying effects in other high-risk prearthritis populations. — Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
Longer abatacept treatment may further reduce progression risk, but the PALABA data do not prove this. — Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial